Clinical Trial Update: The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates Montelukast for non-alcoholic steatohepatitis in Phase 1/2; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Sadat City University | Conditions: Steatohepatitis, Nonalcoholic | Phase 1, Phase 2 | Status: COMPLETED